Authors | Study type | Nation of origin | No. of participants, (n) | Age, median (IQR, y) or Mean ± SD | Serum 25-hidroxyvitamin D [25(OH)D] levels, ng/mL | Follow-up duration (year) | Study quality level | Adjustment |
---|---|---|---|---|---|---|---|---|
Afzal et al. 2014 [14] | Prospective Cohort | Denmark | 352 | 58 | ≤ 25 ng/mL | 21 | 2 | age, sex, month of blood sample, smoking status, body mass index, leisure time, work-related physical activity, alcohol consumption, income level, education, baseline diabetes mellitus, hypertension, cholesterol, HDL cholesterol, and creatinine |
Littlejohns et al. 2014 [15] | Prospective Cohort | United States | 1658 | 73.6 (4.5) | ≤ 25 ng/mL | 5.6 | 3 | Age, season of vitamin D collection, education, sex, BMI, smoking, alcohol consumption, and depressive symptoms |
Karakis et al. 2016 [16] | Prospective Cohort | United States | 1663 | 72.4 | < 10 ng/mL | 9 | 3 | Age, gender, vascular risk factors (smoking, hypertension, diabetes, prevalent cardiovascular disease, and homocysteine), BMI, and vitamin D supplement use |
Feart et al. 2017 [17] | Prospective Cohort | France | 916 | 73.3 | ≤ 25 ng/mL | 12 | 2 | Gender, education, income, depressive symptomatology, number of drugs per day, apolipoprotein E ε4 allele, BMI, practice of physical exercise, diabetes, history of cardiovascular diseases and stroke, hypertension, hypercholesterolemia, hypertriglyceridemia, smoking status, and Mediterranean diet score |
Licher et al. 2017 [18] | Prospective Cohort | Netherlands | 6087 | 82.5 ± 8.6 | ≤ 25 ng/mL | 13.3 | 2 | Age, sex, season of blood collection, BMI, blood pressure, educational level, smoking, alcohol use, calcium serum levels, ethnicity, eGFR, TC, HDL, history of diabetes, heart failure, stroke, myocardial infarction, depressive symptoms, outdoor activity, and APOE-4 carrier status |
Aguilar-Navarro et al. 2019 [19] | Cross sectional | Mexico | 208 | 79 ± 1 | ≤ 20 ng/mL | NR | 3 | Age, sex and years of education |